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Available online 16 September 2015Stellate scar sign is defined as the centrally-placed, well-
defined, stellate area of low density on computed tomog-
raphy (CT) appearance of solid tumors. This kind of radi-
ating enhancement from the center of the tumor, which is
also referred as “a spoke-wheel-like enhancement” or
central scar sign, usually has been recognized as a specific
finding of renal oncocytoma. We describe a patient who
developed clear cell renal cell carcinoma (RCC) displaying
typical stellate scar sign on CT scans, which was confirmed
by gross pathologic appearance.
A 62-year-old Chinese man presented with incidentally
detected renal tumor with once ignored gross hematuria
half a year ago. Ultrasonography found a 5.6 cm hypoecho
mass; CT scans displayed a nearly circular circumscribed
mass in the middle of the left kidney, with inhomogeneous
enhancement during corticomedullary and nephrographic
phases, being an excellent likeness with a spoke wheel
(Fig. 1). His medical history was not significant except that
he had been a heavy smoker for more than 40 years.
Laparoscopic nephrectomy of the left kidney surgery was
performed for a presumed RCC and the patient recovered
uneventfully in postoperative period. The central stellate
scar on CT corresponded to fibrous connective tissue on the
gross pathological examination; and the color of viable
tumor tissue on cross-section is yellow cast of classical
clear cell RCC, but not mahogany color of typical renal
oncocytoma (Fig. 2). Histological examination arrived at
the diagnosis of clear cell RCC.* Corresponding author.
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explanation which is well recognized is that the tumor mass
could outgrow its blood supply as it enlarges, thus leading
to concomitant ischemia; eventually, the ischemic tumor
could be replaced by a fibrotic scar. Because the blood
supply comes from the periphery to the central portion of
the mass, the fibrotic scar is more likely to develop in the
central region of the mass [1]. According to this proposal,
stellate scar sign has nothing to do with pathology. Here we
present a case with a pathologically confirmed clear cell
RCC displaying typical stellate scar sign on CT scans and
gross pathological examination. The case strongly supportsFigure 1 The computerized tomography (CT) appearance of
the tumor showing central low density spoke-wheel-like shape
(arrow) during corticomedullary phase.
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Figure 2 The gross pathologic appearance of the tumor on
cross section: central stellate scar formed by fibrous connec-
tive tissue in otherwise yellow cast and homogenous tumor
tissue.
Stellate scar sign 245the standpoint that a stellate scar sign on CT scan is not
specific for renal oncocytoma and that its existence could
not exclude a diagnosis of RCC [2]. Extra efforts are needed
to achieve the goal of radiological differentiation of onco-
cytoma from RCC [3].
One possible way to differentiate RCC from renal onco-
cytoma is renal tumor biopsy (RTB). However, with its po-
tential unfavorable complications and relatively high
nondiagnostic biopsy rate [4], RTB is not the standardpractice in clinical. What is more, there is a possibility that
RCC could co-exist with oncocytoma in rare cases [5], thus
the benign biopsy tissue would create a clinical dilemma
because it could not rule out a malignant tumor. Thus RTB
has not been commonly accepted by either doctors or
patients.Conflicts of interest
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